Microbicide Innovation Program (MIP VI) (R21/R33)

The summary for the Microbicide Innovation Program (MIP VI) (R21/R33) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Microbicide Innovation Program (MIP VI) (R21/R33): Purpose. This FOA, the Microbicide Innovation Program (MIP VI), issued by NIAID, encourages Research Project Grant (R21/R33) applications in the field of topical microbicides to advance: Development of new microbicide approaches and additional rational targets through preclinical and basic research Discovery and characterization of microbicides (singly or in combinations) directed against HIV or STIs (Sexually Transmitted Infections) that are linked to HIV acquisition The identification and promotion of emerging technologies or models that contribute to the development of new and/or more efficient ways of assessing microbicide safety, efficacy and acceptability Design of complex prevention strategies that incorporate vaginal, rectal, and/or penile applied microbicides. Mechanism of Support. This FOA will utilize the NIH R21/R33 Phased Innovation Award to support innovative exploratory and developmental research. Under the R21 phase research is initiated and carried out through a milestone-driven process to establish the feasibility of new microbicides, microbicide strategies and research that supports microbicide discovery and development. The R33 phase subsequently provides additional support required to further develop the R21 outcomes and, if applicable, translate the innovative discoveries into the preclinical/clinical development pipeline. It is expected that approximately 50% of the R21 awards will transition to the R33 phase. Applications for R21 support alone, or for R33 support alone, are not accepted under this FOA.

Federal Grant Title:	Microbicide Innovation Program (MIP VI) (R21/R33)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-10-011
Type of Funding:	Grant
CFDA Numbers:	93.242
CFDA Descriptions:	Mental Health Research Grants
Current Application Deadline:	Jul 09, 2010
Original Application Deadline:	Jul 09, 2010
Posted Date:	Apr 20, 2010
Creation Date:	Apr 20, 2010
Archive Date:	Aug 09, 2010
Total Program Funding:	$2,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R...; • Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS...; • Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P5...; • Advancing Research on Empirically-Supported Interventions for Older Adults Living with Ser...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...; • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...; • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health: • NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices ...; • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...; • Immune Tolerance Network (UM1 Clinical Trial Required); • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...; • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...